payor coverage

The in-network contracts provide coverage for insured patients in Connecticut, Maine, and New Hampshire for both high- and average-risk pregnancies.

Exact Sciences' CEO recently discussed the added coverage on a call with analysts to discuss Exact's Q4 earnings.

The company said the agreement will make its cancer diagnostics and genomic tests available to more than 2.6 million people.

The coverage is for Paradigm's PCDx test, and will extend to all patients insured by UnitedHealthcare throughout the United States.

Under the agreement, members of the health plan will have covered access to Biocept's growing menu of circulating tumor cell and circulating tumor DNA tests.

Under a national agreement, UnitedHealthcare will cover the FoundationOne genomic profiling assay in patients with metastatic stage IV non-small cell lung cancer.

The ob-gyn groups issued a statement warning that insurers' prior authorization requirements will hinder patients' access to much needed care.